Lonza Cologne GmbH

More stories

• Lonza develops Amaxa nucleofector kits

  Lonza Cologne GmbH18 September 2008

  Lonza has developed Amaxa nucleofector kits for the transfection of primary mouse B cells from single reactions up to 96-well transfections.

• Amaxa nucleofector kit developed by Lonza

  Lonza Cologne GmbH15 August 2008

  Lonza has developed the Amaxa Basic Parasite Nucleofector Kit, providing transfection efficiencies up to 1,000 times higher compared to methods such as electroporation or particle bombardment.

• Webinar covers transfection of stem cells

  Lonza Cologne GmbH1 May 2008

  Amaxa will host a free webinar on the Nucleofection of Stem Cells which is scheduled for 3 June 2008 (Europe, Japan) and 4 June (USA)

• HudsonAlpha Institute adopts Nucleofector

  Lonza Cologne GmbH3 April 2008

  The HudsonAlpha Institute for Biotechnology will utilise Amaxa's Nucleofector technology as a core technology in certain research projects

• Simplified monitoring of signaling in stem cells

  Lonza Cologne GmbH3 April 2008

  Amaxa and Promega will provide cell biologists broader access to monitor cell signaling events in difficult-to- transfect cells, including stem cells, cancer cells and primary cells

More like this